At Celero, we create value for our sponsors with innovative products by focusing on emerging markets. Trial mismanagement is the main reason why 85%-90% of clinical trials fail, leading to the loss of significant resources and funding. Your clinical trial strategy is essential when considering your future market share. Our experts will identify countries with unmet needs, high sales potential and eligible subjects for your trials. Celero's excellence and invaluable experience in project management will ensure that your trial runs smoothly, and timely, and results in data quality of the highest standards. To prevent losses, we provide Strategic Consulting; a one-of-a-kind tailored service with the goal of optimizing Return on Investment from clinical trials, increasing transparency, and accelerating the registration process. Our team has successfully completed 80 clinical trials, including 64 for vaccines, generating over 20 product approvals. We are dedicated to being a key contributor to the financial success of our sponsors' products by providing them market access to emerging markets. If you feel your pipeline products are innovative, possess favourable efficacy and safety profiles and have clear clinical differentiators, we want to talk. Contact us by visiting our website at www.celero.global or reaching out to us at info@celero.global.